Yabuuchi H et al. |
Prominent prolongation of islet xenograft survival in combination therapy with FK 506 and 15-deoxyspergualin. |
1991 |
Transplant. Proc. |
pmid:1703718
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506 in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721261
|
Christians U et al. |
High performance liquid chromatography/mass spectrometry of FK 506 and its metabolites in blood, bile, and urine of liver grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721262
|
Beysens AJ et al. |
FK 506: monitoring in plasma or in whole blood? |
1991 |
Transplant. Proc. |
pmid:1721263
|
Grenier FC et al. |
A whole blood FK 506 assay for the IMx analyzer. |
1991 |
Transplant. Proc. |
pmid:1721264
|
Friob MC et al. |
A combined HPLC-ELISA evaluation of FK 506 in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721265
|
Machida M et al. |
Effect of temperature and hematocrit on plasma concentration of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721266
|
Kawauchi M et al. |
Plasma level of FK 506 in newborn goats and infant baboons. |
1991 |
Transplant. Proc. |
pmid:1721267
|
Iwasaki K et al. |
Pharmacokinetic study of FK 506 in the rat. |
1991 |
Transplant. Proc. |
pmid:1721268
|
Akselband Y et al. |
Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts. |
1991 |
Transplant. Proc. |
pmid:1721292
|
Schreiber SL et al. |
Immunophilin-ligand complexes as probes of intracellular signaling pathways. |
1991 |
Transplant. Proc. |
pmid:1721293
|
Ullman KS et al. |
Site of action of cyclosporine and FK 506 in the pathways of communication between the T-lymphocyte antigen receptor and the early activation genes. |
1991 |
Transplant. Proc. |
pmid:1721294
|
Sigal NH et al. |
Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506? |
1991 |
Transplant. Proc. |
pmid:1721295
|
Bierer BE et al. |
FK 506 and rapamycin: molecular probes of T-lymphocyte activation. |
1991 |
Transplant. Proc. |
pmid:1721296
|
Tanida I et al. |
Yeast cyclophilin-related gene encodes a nonessential second peptidyl-prolyl cis-trans isomerase associated with the secretory pathway. |
1991 |
Transplant. Proc. |
pmid:1721297
|
O'Neill EA et al. |
The FK 506-sensitive nature of the interleukin-2 promoter is derived from a specific array of multiple regulatory elements. |
1991 |
Transplant. Proc. |
pmid:1721298
|
Nelson PA et al. |
Effect of immunosuppressive drugs on cytokine gene transcription studied by message amplification phenotyping (MAPPing) polymerase chain reaction. |
1991 |
Transplant. Proc. |
pmid:1721299
|
Dumont FJ et al. |
Up-regulation of gene expression by FK 506. |
1991 |
Transplant. Proc. |
pmid:1721300
|
Motta I et al. |
FK 506 favors the generation of memory T cells in vitro. |
1991 |
Transplant. Proc. |
pmid:1721324
|
Nakata S et al. |
Immunosuppressive effect of FK 506 on cytotoxic T lymphocytes and delayed-type hypersensitivity in rats. |
1991 |
Transplant. Proc. |
pmid:1721325
|
Cooper MH et al. |
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. |
1991 |
Transplant. Proc. |
pmid:1721326
|
Didlake R and Grogan J |
Effect of FK 506 on rat leukocyte chemotaxis. |
1991 |
Transplant. Proc. |
pmid:1721327
|
Hultsch T and Hohman RJ |
Categorizing receptor-signaling pathways with FK 506 and rapamycin. |
1991 |
Transplant. Proc. |
pmid:1721328
|
Takai K et al. |
Immunosuppressive effects of FK 506 on rat lymphoid organs. |
1991 |
Transplant. Proc. |
pmid:1721329
|
Ishibashi M et al. |
Effect of FK 506 on generation of activated macrophages invading rejected skin allografts in rats: discrepancy of in vitro versus in vivo effects. |
1991 |
Transplant. Proc. |
pmid:1721330
|
Kawauchi M et al. |
Flow cytometric analysis of lymphocyte populations in FK 506-treated newborn goats. |
1991 |
Transplant. Proc. |
pmid:1721331
|
Borg AJ and Kumagai M |
FK 506 and xenogeneic human anti-porcine cellular reactivity. |
1991 |
Transplant. Proc. |
pmid:1721332
|
Whiteside TL et al. |
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. |
1991 |
Transplant. Proc. |
pmid:1721356
|
Van Thiel DH et al. |
Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721357
|
Burman K and Crawford DH |
Effect of FK 506 on Epstein-Barr virus specific cytotoxic T cells. |
1991 |
Lancet |
pmid:1703259
|
Armitage JM et al. |
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1721358
|
Nalesnik MA et al. |
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population. |
1991 |
Transplant. Proc. |
pmid:1703335
|
Armitage JM et al. |
The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1721359
|
Armitage JM et al. |
A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1703336
|
Dew MA et al. |
Quality-of-life advantages of FK 506 vs conventional immunosuppressive drug therapy in cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1721360
|
Gordon RD et al. |
Liver transplantation under cyclosporine: a decade of experience. |
1991 |
Transplant. Proc. |
pmid:1703339
|
Shapiro R et al. |
FK 506 in clinical kidney transplantation. |
1991 |
Transplant. Proc. |
pmid:1721361
|
Todo S et al. |
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. |
1991 |
Transplant. Proc. |
pmid:1703340
|
McCauley J et al. |
Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721362
|
Zeevi A et al. |
Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. |
1991 |
Transplant. Proc. |
pmid:1703341
|
|
Japanese study of FK 506 on kidney transplantation: results of an early phase II study. Japanese FK 506 Study Group. |
1991 |
Transplant. Proc. |
pmid:1721363
|
van Hoek B et al. |
Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome. |
1991 |
Transplant. Proc. |
pmid:1703343
|
Jensen CW et al. |
Pediatric renal transplantation under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721364
|
McCauley J et al. |
The question of FK 506 nephrotoxicity after liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1703344
|
Winkler M et al. |
Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721389
|
Schmidt RJ et al. |
Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721390
|
Tze WJ et al. |
Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. |
1991 |
Transplant. Proc. |
pmid:1721391
|
Doi R et al. |
Mechanisms by which FK 506 affects exocrine pancreas in rats. |
1991 |
Transplant. Proc. |
pmid:1721392
|
Rilo HL et al. |
Effect of FK 506 on function of human islets of Langerhans. |
1991 |
Transplant. Proc. |
pmid:1721393
|
Carroll PB et al. |
Synexin: a target protein for toxic effects of cyclosporine and FK 506 in endocrine cells. |
1991 |
Transplant. Proc. |
pmid:1721394
|
Scantlebury V et al. |
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1721395
|
Carroll PB et al. |
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. |
1991 |
Transplant. Proc. |
pmid:1721396
|
Freise CE et al. |
Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. |
1991 |
Transplant. Proc. |
pmid:1721397
|
Tze WJ et al. |
Long-term survival of islet allografts in diabetic rats treated with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721411
|
Wang X et al. |
Intraportal FK 506 improves intrahepatic islet allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721412
|
Ohtsuka S et al. |
The effect of short-term FK 506 therapy on pancreas transplantation in rats. |
1991 |
Transplant. Proc. |
pmid:1721413
|
Yamashita T et al. |
Prolongation of pancreaticoduodenal allograft survival in rats by treatment with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721414
|
Fukuzaki T et al. |
Induction of tolerance to islet allografts with preoperative donor spleen cell injection and a short course of FK 506 treatment. |
1991 |
Transplant. Proc. |
pmid:1721415
|
Tzakis AG et al. |
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721416
|
Masaoka T et al. |
Phase II study of FK 506 for allogeneic bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721417
|
Markus PM et al. |
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721418
|
Cooper MH et al. |
The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. |
1991 |
Transplant. Proc. |
pmid:1721419
|
Van Duyne GD et al. |
Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. |
1991 |
Science |
pmid:1709302
|
Lim SM and White DJ |
The pharmacology of immunosuppression. |
1991 |
Ann. Acad. Med. Singap. |
pmid:1709344
|
Rosen MK et al. |
Proton and nitrogen sequential assignments and secondary structure determination of the human FK506 and rapamycin binding protein. |
1991 |
Biochemistry |
pmid:1709363
|
Sakr MF et al. |
FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. |
1991 |
Hepatology |
pmid:1709412
|
Hohlfeld R |
[Current therapy of multiple sclerosis: value of cyclosporin A and FK 506]. |
1991 |
Nervenarzt |
pmid:1709725
|
Kay JE et al. |
Inhibition of T and B lymphocyte proliferation by rapamycin. |
1991 |
Immunology |
pmid:1709916
|
Ringe D |
Immunosuppression. Binding by design. |
1991 |
Nature |
pmid:1710317
|
Hasegawa S et al. |
FK 506 and cyclosporine: effects and side effects in canine lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721443
|
Tropschug M and Hofmann R |
FK506 and protein kinase C. |
1991 |
Nature |
pmid:1710319
|
Wada H et al. |
Dose response to FK 506 in canine lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721444
|
Albers MW et al. |
Relationship of FKBP to PKCI-2. |
1991 |
Nature |
pmid:1710782
|
Lin CY et al. |
Effects of FK 506 on the biochemical markers in canine lung allograft rejection. |
1991 |
Transplant. Proc. |
pmid:1721445
|
Stevens C et al. |
The effects of immunosuppressive agents on in vitro production of human immunoglobulins. |
1991 |
Transplantation |
pmid:1710843
|
Propper DJ et al. |
Evidence that FK 506 may abrogate suppressor cell activity induced by blood transfusion. |
1991 |
Transplant. Proc. |
pmid:1721446
|
Fabrega AJ et al. |
FK 506 enhances the beneficial effects of donor-specific blood transfusion on allograft survival in rats. |
1991 |
Transplant. Proc. |
pmid:1721447
|
Davies CB et al. |
Effects of donor-specific transfusion, cyclosporine A and FK 506 on rat cardiac allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721448
|
Abu-Elmagd K et al. |
FK 506: a new therapeutic agent for severe recalcitrant psoriasis. |
1991 |
Transplant. Proc. |
pmid:1721449
|
Nikolaidis NL et al. |
Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases. |
1991 |
Transplant. Proc. |
pmid:1721450
|
Abu-Elmagd K et al. |
Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. |
1991 |
Transplant. Proc. |
pmid:1721451
|
Murase N et al. |
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. |
1991 |
Surgery |
pmid:1714104
|
Lodish HF and Kong N |
Cyclosporin A inhibits an initial step in folding of transferrin within the endoplasmic reticulum. |
1991 |
J. Biol. Chem. |
pmid:1714445
|
Ellis D et al. |
Phospholipase-C and Na-K ATPase activation by cyclosporine and FK506 in LLC-PK1, cells. Possible implications in blood pressure regulation. |
1991 |
Transplantation |
pmid:1714643
|
Simmons RL and Wang SC |
New horizons in immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1714645
|
Calne RY |
Immunosuppression for organ grafting. |
1991 |
Transplant. Proc. |
pmid:1714646
|
Starzl TE et al. |
Notes on FK 506. |
1991 |
Transplant. Proc. |
pmid:1714647
|
Haba T et al. |
Pathological and immunohistochemical examination in the rat treated with FK 506. |
1991 |
Transplant. Proc. |
pmid:1714649
|
Lautenschlager I et al. |
Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts. |
1991 |
Transplant. Proc. |
pmid:1714650
|
Burres NS et al. |
Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. III. Immunosuppressive activities of dunaimycins. |
1991 |
J. Antibiot. |
pmid:1723403
|
Nielsen JB et al. |
Biosynthesis of the immunosuppressant immunomycin: the enzymology of pipecolate incorporation. |
1991 |
Biochemistry |
pmid:2043618
|
Ochiai T et al. |
[Immunosuppressive agents--advances of the developmental studies and the mode of action]. |
1991 |
Nippon Rinsho |
pmid:1715926
|
Jiang H et al. |
Effect of FK-506 on heart allograft survival in the highly sensitized recipient rats as compared with ciclosporin and 15-deoxyspergualin. |
1991 |
Eur Surg Res |
pmid:1723683
|
Fung JJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. |
1991 |
Transplant. Proc. |
pmid:1703682
|
Wu J et al. |
Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation. |
1991 |
Transplant. Proc. |
pmid:1703683
|
Sakai K et al. |
[The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents--comparison with cyclosporin A]. |
1991 |
No To Shinkei |
pmid:1716937
|
Fujino Y et al. |
FK506 treatment of S-antigen induced uveitis in primates. |
1991 |
Curr. Eye Res. |
pmid:1717199
|
Thomson AW |
The immunosuppressive macrolides FK-506 and rapamycin. |
1991 |
Immunol. Lett. |
pmid:1717376
|
Steeves M et al. |
In-vitro interaction of a novel immunosuppressant, FK 506, and antacids. |
1991 |
J. Pharm. Pharmacol. |
pmid:1717676
|
|
Unmasking immunosuppression. |
1991 |
Lancet |
pmid:1717800
|